CollPlant Ltd. (CollPlant) is a biotechnology company. It is engaged in development manufacture and marketing of the collagen biomaterials for the wound care and orthopedic markets. It develops plant-derived collagens, which are used in medical products including bone growth matrices, facial aesthetics, wound dressings, hemostats and sealants. The product portfolio of the company incldue recombinant human type I heterotrimeric atelocollagen, collagen matrix, collagen-based wound dressings, polymer composites and protein-based biomaterials. In addition, CollPlant is developing a pipeline of plant-derived protein polymers and composites used in orthopedics, aesthetic medicine, urinary incontinence and wound healing applications. CollPlant is headquartered in Ness-Ziona, Israel.
Recently, the company signed an agreement with Edwards Lifesciences Corporation, a developer of products and technologies to treat advanced cardiovascular diseases, for the joint development of prototypes of two proprietary collagen-based cardiovascular products.